JPMorgan Chase & Co. Increases Doximity (NYSE:DOCS) Price Target to $31.00

JPMorgan Chase & Co. has raised its price target for Doximity (NYSE:DOCS) to $31.00 from $26.00, maintaining a "neutral" rating, following Doximity's strong quarterly revenue of $156.6 million and EPS of $0.29, which exceeded analyst estimates. The company also raised its full-year revenue outlook and highlighted the strong potential of its clinical AI product. This news led to a significant surge in Doximity shares, reflecting heightened investor interest.